Researchers uncover early bone-health signals hidden in standard tests

Date:

Share this article:

Del denne artikel:

A widely used blood test may reveal early shifts in bone strength long before traditional screening detects any problems.

Many people only discover that their bones have weakened once a scan confirms osteoporosis or after a fracture occurs.

This delay highlights a major public-health challenge: bone loss often develops silently, and many individuals go undiagnosed for years because screening programs typically focus only on those with clear risk factors.

A familiar enzyme gains renewed clinical attention

Standard blood tests already measure several markers linked to liver health, metabolism and inflammation.

Among them is alkaline phosphatase, an enzyme tied to both bone and liver activity. While more specialised bone-turnover markers exist, they are rarely used in everyday practice due to cost and complexity.

Also read: Man suffers stroke after consuming multiple energy drinks

This is why a new analysis from researchers in Chongqing, China, has drawn attention.

Their findings suggest that even small shifts in alkaline phosphatase may relate to early bone weakening, despite values remaining well within the normal medical range.

What researchers found – and why it matters

Using data from thousands of adults undergoing routine health exams, the team compared enzyme levels with DXA scans of the spine and hip.

A consistent pattern emerged: higher enzyme levels aligned with lower bone density. The association was strongest among younger adults, women and individuals with stable metabolic and liver markers, indicating that the enzyme most accurately reflects bone turnover when other systems aren’t interfering.

Also read: The symptom patterns emerging in England’s H3N2 outbreak

Potential influencing factors include:

  • Accelerated bone turnover increasing enzyme release
  • Normal liver function clarifying the enzyme’s origin
  • Metabolic disturbances masking bone-related signals

Implications for earlier detection

If future research supports these findings, alkaline phosphatase could become a practical marker for identifying individuals who should receive bone-density screening earlier than current guidelines suggest.

Such an approach could reduce the high number of undetected cases, a challenge seen worldwide.

Sources: News Medical and Frontiers

Also read: New study: This tea variety is the healthiest choice

Also read: New study explores whether specific nutrients can influence autism-related behavior

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

8 warning signs of colorectal cancer most people mistake for stomach trouble

The earliest clues are quiet, and most people brush them off for months.

1 in 3 adults has fatty liver disease. Scientists just found it comes in 5 distinct forms

A Mayo Clinic study of more than 4,600 patients redraws the map of the most common chronic liver disease.

Before you toss chocolate with a white coating, know what it actually means

The hazy dust is safe to eat, but it reveals how your chocolate has been treated.

Your quick step may quietly reveal seven things about your personality

A prospective study of more than 15,000 adults links walking pace to specific personality traits.

8 warning signs of colorectal cancer most people mistake for stomach trouble

The earliest clues are quiet, and most people brush them off for months.

1 in 3 adults has fatty liver disease. Scientists just found it comes in 5 distinct forms

A Mayo Clinic study of more than 4,600 patients redraws the map of the most common chronic liver disease.

Before you toss chocolate with a white coating, know what it actually means

The hazy dust is safe to eat, but it reveals how your chocolate has been treated.